Cyclacel Pharma (CYCC) Misses Q3 EPS by 18c

November 12, 2024 6:05 PM EST

Cyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.18). Revenue for the quarter came in at $10 thousand.

For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK